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Abstract
Background—Nonmedical prescription drug use is prevalent among young adults, yet little is 
known about modifiable determinants of use. We examined whether maternal-offspring 
attachment reported at mean age 21 was associated with nonmedical prescription opioid use at 
mean age 26, and investigated whether a history of depressive symptoms and substance use played 
a role in associations between maternal-offspring attachment and nonmedical prescription opioid 
use.
Methods—We used data from the Growing Up Today Study, a longitudinal cohort of United 
States adolescents followed into young adulthood. Maternal-offspring attachment was reported by 
young adults and their mothers, and defined as mutual low, mutual medium or high, and dissonant. 
Analyses were carried out in the full sample using generalized estimating equation models, and in 
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a sibling subsample, using conditional fixed effects models to control for stable aspects of the 
family environment.
Results—Analyses with the full sample and the sibling subsample both showed that mutual 
medium/high maternal-offspring attachment at age 21 was associated with lower odds of 
nonmedical prescription opioid use at age 26 (RR=0.74; 95% CI=0.57-0.97 in full sample). The 
association was partly mediated by mean age 23 offspring smoking, heavy episodic drinking, and 
illicit drug use.
Conclusions—Promoting reciprocal attachment in the maternal-offspring dyad should be 
investigated as a strategy to prevent nonmedical prescription opioid use by young adulthood. Even 
in young adulthood, programs that target both parents and offspring may have greater impact on 
offspring substance use than programs that target offspring alone.
Keywords
nonmedical prescription opioid use; maternal-child attachment; sibling fixed effects models; 
mediators
1. Introduction
Nonmedical use of prescription opioids, that is, use for recreational or self-treatment 
purposes without a prescription, or using more medication than prescribed by a physician, is 
an important and growing public health problem in high-income and low-middle-income 
countries (UNODC, 2011). In countries as diverse as Canada, Mexico, Costa Rica, and 
Australia, non-medical prescription opioids account for most of the use of opioids (UNODC, 
2011). Little is known about modifiable determinants of use. Data from the United States 
provides some of the first insights into the epidemiology of non-medical prescription opioid 
use.
In the United States, an estimated 52 million people have used prescription opioids for 
nonmedical reasons at least once in their lifetime (Substance Abuse and Mental Health 
Services Administration (SAMHSA), 2011). Nonmedical prescription opioid use has 
increased dramatically since the early 1990s along with related mortality. While prescription 
opioids are a safe and effective treatment for pain when used as prescribed, unintentional 
overdose deaths due to nonmedical prescription opioid use quadrupled from 1999 to 2010 
and by 2007 outnumbered those involving heroin and cocaine combined (National Institute 
on Drug Abuse, 2011). Women are particularly affected by this increase: deaths from 
prescription opioids increased more than 400% since 1999 for women, compared to 265% 
for men (CDC, 2013). In 2010, approximately 2.4 million Americans used prescription 
opioids nonmedically for the first time, or 6,600 people per day (SAMHSA, 2011).
Young adults (aged 18-25 years) are the age group at highest risk for nonmedical use of 
prescription opioids, with 5.9% reporting past-month nonmedical use in 2010 (SAMHSA, 
2011). The young adult developmental period is characterized by rapid transitions into social 
contexts with more freedom, greater decision-making autonomy, and less exposure to 
external social controls than experienced during adolescence (Stone et al., 2012). 
Concomitant to this greater level of freedom is an increase in the prevalence of substance 
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use and abuse. Understanding factors associated with nonmedical prescription opioid use in 
young adulthood is critical to developing interventions to prevent use and related problems 
(i.e., opioid use disorders) both in the short-term and in later adulthood (Dowling et al., 
2006; Martins et al., 2010).
We focus on a potentially key determinant of young adult prescription opioid use: maternal-
offspring attachment in late adolescence/young adulthood. A parent-offspring relationship 
characterized by secure attachment has been associated with healthy development and 
reduced drug use (Brook et al., 1990). Different aspects of the parent-offspring relationship, 
including parental assertiveness and involvement, parental affection and offspring-
centeredness, and offspring's identification with parents' values, have been inversely 
correlated with drug use (Brook et al., 1990; King and Chassin, 2004; Locke and Newcomb, 
2004; Maggs et al., 1997; Morojele and Brook, 2001; Stone et al., 2012). In the case of 
nonmedical prescription opioid use, however, the evidence is less clear. Harrell and Broman 
(2009) did not find an association between mid-adolescent reports of satisfaction and 
closeness of the maternal relationship and any type of young adult nonmedical prescription 
drug use in Add Health, a nationally representative US sample of young adults (Harrell and 
Broman, 2009). However, contrary to expectations, maternal warmth was associated with 
higher risk of nonmedical prescription drug use among Hispanic respondents, specifically 
(Harrell and Broman, 2009). Collins and colleagues did not detect an association between 
offspring reports of parental monitoring and any nonmedical prescription drug use in a 
sample of Appalachian children and adolescents (Collins et al., 2011). To our knowledge, no 
prior national study has examined the association between the quality of reciprocal 
maternal-offspring attachment, measured from the perspectives of both the mother and the 
offspring, and nonmedical prescription opioid use.
In addition to being understudied, research on the relation between maternal-offspring 
attachment and nonmedical prescription opioid use faces at least two important challenges. 
The first involves confounding. Maternal-offspring attachment occurs along with a broader 
constellation of social and behavioral factors that also influence offspring substance use. 
This poses a challenge to assessing the causal effect of maternal-offspring attachment. 
Family-level characteristics that are potentially confounding factors include family 
socioeconomic status and family violence, as well as maternal characteristics including 
marital status, personality attributes, nonmedical prescription opioid use, and psychiatric 
history (D'Onofrio et al., 2012; Kendler et al., 2013). While some investigators have 
measured some of these factors in studies of maternal-offspring attachment and other types 
of substance use, determining whether or not there is a causal effect of maternal-offspring 
attachment may require accounting for all of them simultaneously as well as other 
unmeasured and unknown confounders.
A second important challenge involves understanding the mechanisms in the offspring that 
connect maternal-offspring attachment to nonmedical prescription opioid use. Comorbid 
offspring psychiatric symptoms and other substance use may constitute central mechanisms 
in the pathway linking maternal-offspring attachment to offspring nonmedical prescription 
opioid use. Low maternal-offspring attachment in adolescence increases the risk for 
offspring depression, which contributes to nonmedical prescription opioid use as a way to 
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self-medicate depressive symptoms (Khantzian, 1997; Martins et al., 2012). At the same 
time, early alcohol use, cigarette smoking, and illicit drug use among offspring with low 
maternal-offspring attachment may serve as a gateway to acquiring and experimenting with 
prescription opioids (Brook et al., 1990). Previous research suggests that depression and 
other substance use precede incident prescription opioid use, but the role that they play in 
the relationship between maternal-offspring attachment and nonmedical prescription opioid 
use is unknown (McCabe et al., 2005, 2008; McCabe and Teter, 2007; Pletcher et al., 2006).
In the current study, we conducted an analysis of maternal-offspring attachment in relation 
to offspring nonmedical prescription opioid use in the context of a prospective cohort study 
in which multiple offspring per family were enrolled. The power of this design comes from 
sibships in which there was variability in maternal-offspring attachment and nonmedical 
prescription opioid use, but similarity in the shared familial environment (Lahey and 
D'Onofrio, 2010). Hence, differences in nonmedical prescription opioid use between 
exposed and unexposed siblings could not be attributed to shared aspects of the familial 
environment, ranging from some shared inherited genetic susceptibility and family history 
of nonmedical prescription opioid use to shared environmental factors. This design consists 
of a comparison of siblings matched on family background, in which estimates of 
nonmedical prescription opioid use risk are conditioned on family-specific intercepts.
This study had two aims: (1) to examine the association between maternal-offspring 
attachment in late adolescence/young adulthood and nonmedical prescription opioid use in 
young adulthood; and (2) to evaluate whether offspring depressive symptoms and substance 
use (i.e., heavy episodic drinking, cigarette smoking, marijuana, and other illicit substance 
use) reported following maternal-offspring attachment and prior to nonmedical prescription 
opioid use explain the association between maternal-offspring attachment and nonmedical 
prescription opioid use in young adulthood. Analyses were conducted in the full sample as 
well as in a sibling subsample.
2. Methods
2.1 Study sample
The Growing Up Today Study (GUTS) is an ongoing cohort study enrolled in 1996 with 
offspring of women participating in the Nurses' Health Study II (NHS II). NHS II is a 
prospective cohort of female nurses. The study, begun in 1989, recruited 116,430 nurses 
aged 25-44 nationwide and has since followed them biennially. Nurses with offspring of 
ages 9-14 (N=34,174) were requested permission to recruit their offspring into GUTS. A 
baseline questionnaire was mailed to the nurses who granted consent (54%). Of their 
children, 9,039 girls (68%) and 7,843 boys (58%) returned the baseline questionnaire and 
were enrolled. Since baseline, GUTS participants have completed 11 questionnaires, initially 
on an annual basis and every two years since 2001. Participants who missed a questionnaire 
were retained in subsequent waves. A detailed description of the GUTS cohort is available 
(Field et al., 1999)
This analysis was conducted among all GUTS participants who responded to 2010 questions 
about past-year nonmedical prescription opioid use (hereafter referred to as “full sample, 
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n=7,746”) and in a subsample consisting of the sibling pairs in which at least one of the 
siblings reported past-year nonmedical prescription opioid use on at least one occasion 
(number of young adults = 290, number of families=139), hereafter referred to as the 
“sibling subsample.” This study was approved by the Brigham and Women's Hospital 
Institutional Review Board. Study participants provided informed consent prior to 
participating in the study.
2.2 Study Measures
Table 1 shows timing of assessment of the variables used in the analyses. To summarize, to 
establish a temporal order, confounders were measured before assessment of the exposure of 
interest (maternal-offspring attachment), while potential mediators were assessed between 
assessments of the exposure and outcome and were operationalized to reflect status in the 
year following exposure assessment. Hence, maternal-level confounders were measured in 
2001 and 2003, offspring-level confounders were assessed in 2003; offspring and maternal 
reports of the exposure were assessed in 2005 and 2006 respectively; offspring reports of 
potential mediators (i.e., offspring substance use) were assessed in 2007; and offspring 
reports of the outcome (past year nonmedical prescription opioid use) were assessed in 
2010.
2.2.1 Offspring reports of the outcome, 2010—The main outcome of this study was 
frequency of past-year use of prescription opioids without a doctor's prescription. In the 
2010 GUTS questionnaire, respondents who answered yes to the question: “Have you ever 
used any pain killers (e.g., Percocet, Percodan, Oxycontin, Oxycodone, codeine, morphine) 
without a doctor's prescription?” were asked to indicate frequency of use in the prior 12 
months. The answer options included: Not in past year, 1 time, 2-5 times, 6-10 times, 11-15 
times, 16+ times. Participants who endorsed the “Not in past year” option in the 
questionnaire and those who indicated that they have never used painkillers were classified 
as non-past-year users.
2.2.2 Exposure: Maternal and offspring reports of maternal-offspring 
attachment, 2005-2006—Youth/young adults (GUTS, 2005) and mothers (NHS II, 2006) 
were asked to complete an identical 9-question scale questionnaire that assessed the quality 
of their relationship. Mothers completed separate scales for each offspring they had in the 
study. The scale was developed for research in adolescents and has been shown to correlate 
highly with other more complex measures of quality of relationships (Dittus and Jaccard, 
2000; Jaccard and Dittus, 2000; Jaccard et al., 1996). The scale had high internal 
consistency reliability in the sample of mothers and offspring (Cronbach's α = 0.94 for 
mothers and α = 0.94 for offspring). The mother and offspring reports (Spearman's r=0.43; p 
<0.001) and the sibling reports (Spearman's r=0.19; p=0.02) were significantly correlated 
with each other.
Young adults and mothers rated their dissatisfaction regarding aspects of the relationship 
including affection, emotional support, conflict resolution, respect, and communication in a 
5-point scale with higher score indicating more dissatisfaction. For each young adult and 
mother's report an overall attachment score was computed as the sum of the answers to the 
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nine items. Medium-high attachment was defined as the bottom 75% of the score 
distributions. Low attachment was defined as the top 25%. The maternal and offspring 
scores were then combined to create a 4-level attachment variable: (1) mutual medium-high 
(medium-high young adult – medium-high mother attachment ratings); (2) medium-high 
young adult – low mother attachment ratings, (3) low young adult – medium-high mother 
attachment ratings and (4) mutual low (low young adult-low mother attachment ratings).
2.2.3 Mediators, 2007—Mediators were offspring characteristics considered to 
potentially be in the pathway between maternal-offspring attachment and offspring non-
medical use of prescription drugs. All mediators were assessed in GUTS 2007 and were 
operationalized to indicate presence/absence of the mediator in the year following exposure 
assessment.
Depressive symptoms in the past week were assessed with the 10-item Center for 
Epidemiological Studies Depression scale (CESD-10; Kohout et al., 1993). The items 
covered depressed mood, guilt, worthlessness, helplessness, psychomotor retardation, and 
appetite and sleep disturbances experienced on the past week. The overall score was 
dichotomized, as recommended, with a score of 11 or higher indicating mild or severe 
depressive symptomatology (Andresen et al., 1994).
We defined heavy episodic use of alcohol as drinking five or more alcoholic beverages over 
a few hours on more than five occasions in the past year for males and drinking four or more 
alcoholic beverages in this same time frame for females.
Smoking was defined as (1) never, (2) past (participant has a history of smoking but has not 
smoked in past year), and (3) current (smoking within past year).
We created a binary variable to reflect past year use of marijuana and another binary 
variable -“other illicit drugs”- to reflect past year use of cocaine, LSD, heroin, GHB, 
ecstasy, crystal methamphetamine, or other amphetamines.
2.2.4 Confounders—Confounders, listed below, were maternal and young adult 
characteristics commonly associated with either maternal-offspring attachment or offspring 
non-medical use of prescription drugs. Each confounder was measured using the most 
detailed assessment available that was conducted prior to, and closest in time to, the 
assessment of maternal-offspring attachment.
2.2.4.1 Maternal characteristics: NHS II, 2001-2003: We used the 2001 questionnaire to 
assess maternal depressive symptoms with the 5-item Mental Health Index (MHI-5) overall 
test score (Rumpf et al., 2001) and to measure household income (categorized in this study 
as 1=<50,000, 2=50,000-74,999, 3=75,000-99,000, 4>99,000). We used the 2003 
questionnaire to assess maternal smoking, categorized as Ever/Never smoking.
2.2.4.2 Young adult characteristics (GUTS baseline and 2003): Young adult depressive 
symptoms were assessed in 2003 using 6 items of the previously validated McKnight Risk 
Factor Survey (MRFS) (Shisslak et al., 1999). We computed mean scores for respondents 
who answered at least four of the questions. Young adult's prior heavy episodic use of 
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alcohol assessed in 2003 was defined as drinking 5 (for males) or 4 (for females) or more 
alcoholic beverages over a few hours on more than five occasions in the past year. Smoking 
was defined as (1) never, (2) past (participant has a history of smoking but has not smoked 
in past year), and (3) current (smoking within past year). Past-year use of marijuana was 
categorized as yes/no. Other characteristics were baseline young adult's age (continuous), 
sex (male/female), and race/ethnicity (white/non-white).
Missing covariate information was assumed to be at random and was imputed using the R 
Mi package (Su, 2011)
2.3 Statistical analysis
2.3.1 Analysis in the full sample—We examined the relationship between maternal-
offspring attachment and offspring's frequency of past year nonmedical prescription opioid 
use. We modeled the relative rate of past year nonmedical prescription opioid use using 
generalized estimating equations with a Poisson distribution, while accounting for familial 
correlation of data (Lipsitz et al., 1991). The first model controlled for socio-demographic 
confounders (Model 1: offspring's age, race/ethnicity, sex and family income); we then 
added pre-exposure maternal and offspring mental health history as potential confounders 
(Model 2: maternal depressive symptoms and smoking status, and offspring's history of 
depressive symptoms, heavy episodic alcohol use, smoking, and marijuana use). In 
sequential models we separately added potential mediators, assessed between the exposure 
and the outcome: offspring past week depressive symptomatology (Model 3a), past-year 
smoking and use of alcohol (Model 3b), past-year marijuana use (Model 3c), and past-year 
use of other illicit drugs (Model 3d). A final model adjusted for all potential mediators 
(Model 3e).
2.3.2 Analysis in siblings subsample—We used a matched, or fixed effects, (Allison, 
2005) sibling analysis to examine the relationship between maternal-offspring attachment 
and frequency of past-year nonmedical prescription opioid use in the sibling subsample. 
This analysis assumes that effects of maternal variables are similar in siblings (Rutter et al., 
2001). The matched analyses among siblings were conducted by using Poisson regression 
with dummy variables for all families (less one) with correction for overdispersion. Only 
potential confounders that differed among siblings were included in the sibling fixed-effects 
models, as observed and unobserved confounders that were shared among siblings (e.g., 
maternal characteristics) were accounted for by the sibling design. In these models, we 
adjusted for pre-exposure offspring history of depressive symptomatology, smoking, heavy 
episodic drinking, marijuana use, age, sex, and race/ethnicity. Only families in which at least 
one of the siblings reported some past-year use of prescription opioids were kept in the 
analytic sample (Number of participants=290, number of families=139). In subsequent and 
separate models we further adjusted for potential mediators: post-exposure offspring 
depressive symptomatology, smoking and heavy episodic drinking, and use of illicit drugs. 
All analyses were conducted in SAS 9.3 (2002).
2.3.3 Sensitivity analyses in sibling subsample—Our analysis relied on offspring 
and maternal reports of maternal-offspring attachment and examined the role they played in 
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the risk for nonmedical prescription opioid use. This reliance on offspring-specific reports of 
maternal-offspring attachment could lead to confounding, as offspring-specific factors could 
lead siblings to perceive the same objective maternal relationship differently (and thus to 
have different probabilities of being classified as having concordant maternal-offspring 
attachment) and could also contribute to between-sibling differences in the risk of young 
adult nonmedical prescription opioid use. We conducted a sensitivity analysis using only 
one rater across siblings (the mother) to examine this possibility. We estimated the 
relationship between maternal reports of maternal-offspring attachment and the risk of 
nonmedical prescription opioid use.
3. Results
Characteristics of the full 2010 GUTS sample and of the sibling sub-sample used in our 
analyses are shown in Table 2. The 2010 prevalence of past-year nonmedical prescription 
opioid use was 7%. Young adult respondents were aged 18-26 (mean age 21) years old 
when offspring attachment was measured, 19-26 (mean age 22) when maternal attachment 
was measured, and 23-30 (mean age 26) years old when we measured past-year nonmedical 
prescription opioid use. Of the 7,646 GUTS participants who responded to the 2010 question 
on past-year nonmedical prescription opioid use (full-sample), 290 (3.8%) were included in 
our sibling analysis, as they each had a sibling in the study and, within each of those 
families, at least one sibling had reported past-year use of nonmedical opioids in 2010. Due 
to this inclusion criteria, 51.38% of the sibling sample had used prescription opioids in the 
past year.
3.1 Analysis in the full sample
Adjusting for sex, race/ethnicity, and age, the frequency of past-year nonmedical 
prescription opioid use among young adults with mutual medium-high maternal-offspring 
attachment was half that of young adults who had mutual low maternal-offspring attachment 
(Risk ratio (RR)=0.50, 95% Confidence Interval (CI)=0.38-0.65) (Table 3). Further 
adjustment for maternal history of depressive symptoms and smoking and offspring's history 
of depressive symptoms, smoking, heavy episodic use of alcohol, and marijuana use, all 
assessed prior to assessment of attachment, slightly reduced the association between mutual 
medium/high attachment and nonmedical prescription opioid use (RR=0.74, 95% 
CI=0.57-0.97). We next tested whether offspring's depressive symptoms and other types of 
substance use, measured after assessment of attachment, mediated the relationship between 
attachment and nonmedical prescription opioid use. The beta coefficient for the main effect 
was attenuated by 10%, 18%, 7%, and 16% upon adjustment for depressive symptoms 
(Model 3a), heavy episodic use of alcohol and smoking (Model 3b), marijuana (Model 3c), 
and other illicit drug use (Model 3d), respectively. In a final model that included all potential 
mediators the beta coefficient was attenuated by 39% (Model 3e).
3.2 Analysis in siblings subsample
Adjusting for sex, race/ethnicity, and age, the frequency of past-year nonmedical 
prescription opioid use among young adults with mutual medium-high maternal-offspring 
attachment was a quarter of that of their siblings who had mutual low maternal-offspring 
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attachment (RR=0.22, 95% CI =0.09-0.54) (Model 1; Table 4). After further adjustment for 
young adult's pre-exposure history of depressive symptoms, smoking, heavy episodic 
drinking, and use of marijuana, the association between mutual medium-high attachment 
and nonmedical prescription opioid use remained unchanged (RR=0.29, 95% CI=0.12-0.74). 
In subsequent models that tested whether offspring's post-exposure depressive symptoms 
and other types of substance use mediated the relationship, smoking and heavy episodic use 
of alcohol (Model 3b), and other illicit drug use (Model 3d) attenuated the beta coefficient 
of the main effect by 21% and 18 % respectively. In a final model that included all potential 
mediators the beta coefficient was attenuated by 28% (Model 3e). Sensitivity analyses in the 
sibling subsample using only maternal reports on maternal-offspring attachment (Table 5), 
found comparable results to the main sibling analysis.
4. Discussion
Maternal-offspring attachment in late adolescence/young adulthood was associated with 
lower risk for offspring nonmedical prescription opioid use in young adulthood. The 
consistent findings in the full sample and the siblings fixed-effects analysis of prevalent 
nonmedical prescription opioid use indicate that the association is likely not due to family-
level sources of confounding shared between siblings. Our findings fit within a broader body 
of work on substance use, which found that close and supportive relationships characterized 
by secure parent-offspring attachment were protective against substance use (Fang et al., 
2010; King and Chassin, 2004; Maggs et al., 1997; Morojele and Brook, 2001; Stone et al., 
2012). Interventions aimed at promoting mother-child attachment in early childhood have 
been effective in preventing long-term adverse health outcomes in the offspring (Geeraert et 
al., 2004; Olds, 2006; Olds et al., 2007); this study highlights the persistent influence that 
promoting secure maternal-child attachment can have on nonmedical prescription opioid use 
even in young adulthood.
A key strength of this study is the use of both maternal and offspring reports of maternal-
offspring attachment. Through this dyadic approach, we found that concordance in maternal-
offspring attachment (i.e., medium-high attachment reported by both the mother and the 
offspring) distinguished nonmedical prescription opioid use from non-use. Cases of 
discordant attachment (i.e., medium-high maternally-perceived attachment but low 
offspring-perceived attachment, or low maternally-perceived attachment but medium-high 
offspring-perceived attachment), did not have significantly different levels of risk of 
nonmedical prescription opioid use from individuals with concordant low offspring-mother 
perceptions of attachment. With the use of a dyadic measure, we could conclude that what 
mattered was reciprocal attachment between the mother and offspring, rather than just the 
offspring's perception of attachment. The lack of consistent findings in previous studies that 
examined the association between maternal warmth (Harrell and Broman, 2009) or parental 
monitoring (Collins et al., 2011) and nonmedical prescription opioid use may be partly due 
to the reliance on offspring reports of the maternal-offspring relationship that obscure the 
distinctions between reciprocal high quality relationships and unidirectional perceptions of 
such relationships.
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Maternal-offspring attachment may influence nonmedical prescription opioid use through a 
variety of pathways, including by communicating parental disapproval of nonmedical 
prescription opioid use and other types of drugs (Collins et al., 2011; Sung et al., 2005) and 
by preventing diversion of drugs from family members' prescribed medications (Ford and 
Lacerenza, 2011). We tested one pathway connecting maternal-offspring attachment to 
nonmedical prescription opioid use: depressive symptoms and engagement in alcohol, 
tobacco or illicit drug use. We found that the association between maternal-child attachment 
and nonmedical prescription opioid use was partly mediated by intervening levels of 
smoking, heavy alcohol use, and other types of illicit drug use. Multiple studies have found 
an overlap between nonmedical prescription opioid use and other drug use behaviors, 
including cigarette smoking, heavy drinking, marijuana use, and other illicit drug use 
(Bardhi et al., 2007; Blanco et al., 2007; Boyd et al., 2004, 2009; Catalano et al., 2011; 
McCabe et al., 2009, 2007, 2006, 2008). Nonmedical prescription opioid use may be another 
type of drug used by youth engaged in polydrug use. Low maternal-child attachment may 
contribute to earlier initiation of alcohol, tobacco, and illegal drugs, which may lead youth to 
find out where and how to access prescription drugs, thus placing them at greater risk for 
nonmedical prescription opioid use (Viana et al., 2012).
Our findings should be considered with the following limitations. First, we were unable to 
examine the association between maternal-offspring attachment and incident nonmedical 
prescription opioid use due to statistical power considerations in the sibling subsample. 
Future studies will have to determine whether maternal-offspring attachment is associated 
with incident nonmedical prescription opioid use. However, the availability of prospective 
data on confounders, exposures, and mediators allowed us to establish a temporal order in 
these measures and to assess whether changes in substance use and depressive symptoms 
pre- vs. post-measurement of attachment explained the association between maternal-
offspring attachment and nonmedical prescription opioid use. Second, our sample was 
predominantly White; findings may not apply to other populations. Third, the sibling 
analysis imposed important restrictions on the analytic sample; unmeasured offspring-level 
confounders such as temperament could have contributed to the between-sibling discordance 
in nonmedical prescription opioid use and in attachment. Fourth, we did not measure 
maternal-offspring attachment in childhood; the effect of maternal-offspring attachment on 
non-medical prescription opioid use may be stronger in childhood and early adolescence. 
Fifth, we were unable to distinguish nonmedical use of opioids for recreational versus self-
treatment purposes; future studies need to examine the specific impact of maternal-offspring 
attachment on each type of nonmedical prescription opioid use. Sixth, while parents may 
protect offspring against engagement in nonmedical use of prescription opioids, they may 
also be a source of diverted prescription opioids—the moderate effect of maternal-offspring 
attachment on nonmedical prescription opioid use may be due to this dual role played by 
families in the case of prescription opioids.
Reciprocal attachment between mother and offspring is associated with lower risk of 
nonmedical prescription opioid use in young adults. The findings suggest that family 
substance use prevention interventions may need to work with families as a unit in order to 
have an impact on nonmedical prescription opioid use. Further, parenting programs that 
work with young parents to improve psychosocial and developmental outcomes in parents 
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and children may be a promising strategy to prevent offspring nonmedical prescription 
opioid use by promoting a closer parent-offspring relationship (Barlow et al., 2011; Scharfe, 
2011).
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